在神经治疗发现和开发中的PET
1Azrieli Centre for Neuro-Radiochemistry, Brain Health Imaging Centre, Centre for Addiction and Mental Health, Campbell Family Mental Health Research Institute, Toronto, Canada; Institute of Medical Science, Temerty Faculty of Medicine, University of Toronto, Canada.
概括
定子发射断层扫描 (PET) 能够在体内追踪中枢神经系统 (CNS) 药物发现的药物分子. 这一观点强调了PET放射性体在精神病学,神经瘤学和神经退行研究中的应用.
科学领域:
- 神经科学是一个神经科学.
- 放射化学 放射化学是指辐射化学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 定子发射断层扫描 (PET) 是一种敏感的定量成像技术.
- PET允许在体内跟踪放射性标记的分子,而不会改变它们的特性.
- 它是从临床前阶段到临床阶段的药物发现的宝贵工具.
研究的目的:
- 讨论PET放射性连体在中枢神经系统 (CNS) 的应用. 药物发现和开发.
- 为突出精神病学,神经瘤学和神经退行症的最新进展.
- 探索开发新型中枢神经系统放射标记物的挑战.
主要方法:
- 使用子发射放射性核酸被纳入感兴趣的分子.
- 在体内评估药理动力学和药理动力学 (PK/PD) 特性.
- 为特定的中枢神经系统目标开发和应用新型无线电追踪器.
主要成果:
- 佩特促进生物标志物验证,PK/PD评估和目标参与研究.
- 应用包括5-HT2A,11β-HSD1,KRASG12C,ATM,ALK2,粉样β斑块,以及MAPK p38.
- 在确定最佳剂量方案和为临床试验选择患者方面,PET有助于确定最佳剂量方案.
结论:
- PET成像对于推动中枢神经系统药物发现和开发至关重要.
- 它提供了对生物标志物功能和治疗反应的定量见解.
- 新型PET放射性连接体为理解和治疗神经系统疾病提供了显著的潜力.
关键词:
碳-11 碳-11 是一种碳.-18 -18 -18 -18 -18 -18 -18神经成像是一种神经成像.定子发射断层扫描 (PET) 是一种定子发射断层扫描.放射化学 放射化学是指辐射化学.小分子药物开发小分子药物开发更多相关视频
06:38Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
11.2K
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
13.6K
相关概念视频
01:26Drug Discovery: Overview
10.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.4K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K